Acceptys, Inc., a biotechnology company, engages in the development of human antibody therapies in cancer and infectious diseases. It offers anti-cancer and anti-viral human antibodies for lung, pancreatic, gastric, and/or colon cancers. The company was founded in 2002 and is based in Sparta, New Jersey. As of December 3, 2008, Acceptys, Inc. operates as a subsidiary of Patrys Limited.